Direkt zum Inhalt
Merck

Inhibitory effects of acetylsalicylic acid on exocrine pancreatic carcinogenesis.

Biotechnic & histochemistry : official publication of the Biological Stain Commission (2013-01-22)
H Yıldız, H Oztas, D Yıldız, A Koc, E Kalipci
ZUSAMMENFASSUNG

We investigated short (6 months) and long (12 months) term inhibitory effects of low (200 ppm) and high (400 ppm) dosages of acetylsalicylic acid (aspirin) on exocrine pancreatic carcinogenesis. It is known that exocrine pancreatic carcinogenesis can be detected by the presence of atypical acinar cell foci (AACF) in pancreas. We investigated possible inhibitory effects of acetylsalicylic acid in an azaserine-treated rat model. AACF were produced in rats by injection with azaserine according to previous studies. Our findings showed that the number, volume and diameter of pancreatic AACF were reduced after acetylsalicylic acid application. These observations suggest that acetylsalicylic acid may exert a protective effect against neoplastic development of pancreatic acinar cells in azaserine injected rats. Our findings corroborate reports in the literature concerning the effects of aspirin in reducing neoplastic development.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Acetylsalicylsäure, ≥99.0%
Supelco
Aspirin (Acetylsalicylsäure), Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Aspirin, meets USP testing specifications
USP
Aspirin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Acetylsalicylsäure, analytical standard
Acetylsalicylsäure, European Pharmacopoeia (EP) Reference Standard
Acetylsalicylsäure für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard